Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: After further investigation,

<"...How many times do we read a press release from different companies indicating they have agreed to this or that pending the approval of shareholders?...">

We hear it alot, but what shareholders? I would assume in most, if not all cases, it is the shareholders of the company being purchased that the deal hinges on. Am I wrong? Opty

Share
New Message
Please login to post a reply